News-Yaohai Biopharmaceutical Co., Ltd.

News

PepTalk 2025

Dec 27, 2024

🌟Yaohai sincerely invites you to meet with us at PepTalk 2025🌟 We are thrilled to extend a warm invitation to the PepTalk 2025 event, the premier global event for the biotechnology and pharmaceutical industries, to ignite innovation from January 13th...

BIO-EUROPE 2024
Oct 22, 2024
🌟Yaohai sincerely invites you to meet with us at BIO EU 2024🌟 We are thrilled to extend a warm invitation to the BIO EU 2024 event, the premier global event for the biotechnology and pharmaceutical industries, to ignite innovation from November 4th t...
Read More
CPHI Milan 2024
Oct 08, 2024
The biggest trade fair for the pharmaceutical industry, CPHI Worldwide, will take place in Milan, Italy, from 8 to 10 October 2024 at the Fiera Milano Exhibition Center. CPHI is known to give a platform for anyone in the industry to create connectio...
Read More
FCE COSMETIQUE
Jun 04, 2024
The FCE Cosmetique 2024, a cosmetics exhibition in São Paulo, Brazil, will be held from June 4th to June 6th, 2024. This exhibition is one of the largest and most comprehensive cosmetics industry expos in South America. It provides knowledge ...
Read More
BIO International Convention 2024
Jun 03, 2024
BIO International Convention 2024, Dates: 6/3/2024 - 6/6/2024 Venue: San Diego Convention Center. The BIO exhibition is the world's largest biotechnology event, allowing exhibitors to connect with top executives and influential decision-makers who a...
Read More
CPHI North America 2024
May 07, 2024
The CPHI North American is the only pharmaceutical industry event in the United States that covers the entire industry chain of drug research and development, production, packaging, and more. The exhibition will continue to be held in the heavy indu...
Read More
2024 WORLD VACCINE CONGRESS Washington
Apr 01, 2024
The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meetings of their kind across the globe. Following a record attendance in 2023 of 3000+ attendees...
Read More
BiotechGate, Online
May 13, 2024
BiotechGate Digital Partnering is an innovative online platform that connects global biopharma or biotech companies and services & solutions providers (like CROs and CDMOs). It provides biopharma, biotech, and CRO & CDMO enterprises with a virtual bo...
Read More
VLP Vaccine: A Novel Approach to Combat Mosquito-Borne Viruses
Feb 19, 2025
Virus-like particles (VLPs), non-infectious proteins mimicking viruses, are crucial in vaccine development. Texas Tech University researchers created a multivalent VLP vaccine targeting Chikungunya (CHIKV), Japanese Encephalitis (JEV), Yellow Fever (...
Read More
Quality Control and Applications of Recombinant Proteins
Feb 18, 2025
Quality control of recombinant proteins is crucial for the reliability and reproducibility of experimental data. Every step, from project design to production process, requires stringent quality control strategies. Quality Control Strategies The indu...
Read More
Plasmid: A Small Circular DNA Molecule with Big Potential
Feb 14, 2025
Plasmids, small circular DNA molecules, serve as essential vectors for DNA recombination in molecular biology research and gene therapy. The yield and quality of plasmids are crucial, with supercoiled proportion and endotoxin content being two signif...
Read More
Optimizing the Purification Process for Recombinant Human Insulin
Feb 13, 2025
In recent years, diabetes patient growth has driven insulin demand, but affordable insulin is in short supply. Efficient, economical insulin production is crucial. Mainly produced via Escherichia coli (E. coli) and yeast due to rapid growth and low c...
Read More
Yeast cells for recombinant protein production
Feb 12, 2025
Traditional methods for acquiring pharmaceutical raw materials, such as plant extraction or relying on natural organisms, face challenges like long growth cycles and limited yields. Microbial recombinant protein synthesis technology, particularly usi...
Read More
Optimizing E. coli Cellular Integrity for Biopharma Production
Feb 06, 2025
In the field of biopharmaceuticals, Escherichia coli (E. coli) plays a vital role as a host for the expression of recombinant proteins. The cellular integrity of E. coli is crucial for protein yield, quality, and production costs. This integrity prim...
Read More
Codon Optimization Strategies
Feb 05, 2025
There are 64 genetic codons, of which 60 encode 20 amino acids. Every organism used for protein expression or production (including Escherichia coli, yeast, mammalian cells, Pichia, plant cells, and insect cells) exhibits some degree of difference or...
Read More
Overcoming Challenges in Therapeutic Protein Purification
Jan 23, 2025
In recent decades, recombinant proteins have proven crucial in combating various diseases, demonstrating great potential. With advancements in genetic engineering, significant breakthroughs have been made in protein drug research. Technologies like f...
Read More
IVT mRNA Preparation
Jan 22, 2025
In vitro transcription (IVT) is the preferred method for preparing mRNA, capable of yielding micrograms to milligrams of mRNA on a laboratory scale. For research purposes, reagent suppliers have developed versatile IVT reaction systems suitable for m...
Read More
Minicircle DNA: Unlocking Gene Therapy's Future
Jan 21, 2025
Gene therapy, as a cutting-edge therapeutic approach, brings new hope for numerous incurable diseases. Among them, minicircle DNA (mcDNA), serving as a non-viral DNA carrier, is gradually demonstrating its unique charm. Introduction of mcDNA mc...
Read More
Monoclonal Antibodies Production in E. coli: Advances and Prospects
Jan 16, 2025
Monoclonal antibodies (mAbs), which are soluble glycoproteins of approximately 150 kDa consisting of heavy and light chains, are widely used in the treatment of cancers and autoimmune diseases. In recent years, the production methods of mAbs and thei...
Read More
Universal mRNA Vaccines: Combating Influenza for Global Health
Jan 15, 2025
Influenza viruses, particularly types A and B, annually trigger global health crises and economic losses. Their high mutation rate and ability to undergo genetic recombination make traditional vaccines difficult to provide long-term protection. In re...
Read More